key: cord-0887380-v5r1tl6r
authors: Harit, R.; De, S.; Singh, P. K.; Kashyap, D.; Kumar, M.; Sahu, D.; Yadav, C. P.; Mohan, M.; Singh, V.; Tomar, R. S.; Pandey, K. C.; Vashisht, K.
title: C allele of rs479200 of the host EGLN1 gene - a risk factor for severe COVID-19 (pilot study)
date: 2022-03-14
journal: nan
DOI: 10.1101/2022.03.11.22272214
sha: 9d122a7f33e54c976aaa17161c6b8c5ddf03516f
doc_id: 887380
cord_uid: v5r1tl6r

Abstract Background Coronavirus disease-2019 (COVID-19) symptoms can range from asymptomatic, moderate to severe manifestations that result in an overall global case fatality rate of 2-7 %. While each variant has had it challenges, and some variants are more severe than others, risk factors of severe COVID-19 are still under investigation. In this context, the host genetic predisposition is also a crucial factor to investigate. In the present study, we investigated host genotypes of the SNP rs479200 of the host EGLN1 gene, previously implicated in high altitude pulmonary edema (HAPE), some of whose symptoms such as hypoxia profoundly overlap with severe COVID-19. Methods After informed consent, 158 RT-PCR confirmed COVID-19 patients (March 2020 to June 2021) were enrolled in the study. Based on their clinical manifestations, disease severity was categorized by the clinical team. Blood samples were drawn and DNA was extracted from the clot to infer different genotypes of the SNP rs479200 of the host EGLN1 gene. PCR-RFLP analysis of the SNP rs479200 (C > T) was performed with an amplicon size of 367 bp. Various genotypes (TT, TC and CC) were assigned based on the presence/absence of a restriction site (T/GTACA) for restriction enzyme BsrGI. Allele frequencies, Hardy-Weinberg Equilibrium (HWE) and multinomial logistic regression were performed using statistical tool SPSS version 23 (IBM). Findings We observed that the severe COVID-19 category was composed of comparatively younger patients with mean age (34.9), compared to asymptomatic and moderate categories whose mean age was 49.7 and 54.3, respectively. Preponderance of males and high heterozygosity (TC) was observed across the clinical categories. Notably, the frequency of C allele (0.664) was 2-fold higher than the T allele (0.336) in severe COVID-19 patients, whereas the allele frequencies were similar in asymptomatic and moderate category of COVID-19 patients. Multinomial logistic regression showed an association of genotypes with increasing clinical severity; odds ratio (adjusted OR- 11.414 (2.564-50.812)) and (unadjusted OR- 6.214 (1.84-20.99)) for the genotype CC in severe category of COVID-19. Interestingly, the TC genotype was also found to be positively associated with severe outcome (unadjusted OR-5.816 (1.489-22.709)), indicating association of C allele in imparting the risk of severe outcome. Interpretation The study provides strong evidence that the presence of C allele of SNP (rs479200) of the EGLN1 gene associates with severity in COVID-19 patients. Thus, the presence of C allele may be a risk factor for COVID-19 severity. This study opens new avenues towards risk assessment that include EGLN1 (rs479200) genotype testing and identifying patients with C allele who might be prioritized for critical care.

We observed that the severe COVID-19 category was composed of comparatively younger 2 patients with mean age (34.9±15.6), compared to asymptomatic and moderate categories whose 3 mean age was 49.7±17.9 and 54.3±15.7, respectively. Preponderance of males and high 4 heterozygosity (TC) was observed across the clinical categories. Notably, the frequency of C 5 allele (0.664) was 2-fold higher than the T allele (0.336) in severe COVID-19 patients, whereas 6 the allele frequencies were similar in asymptomatic and moderate category of COVID-19 7 patients. Multinomial logistic regression showed an association of genotypes with increasing 8 clinical severity; odds ratio (adjusted OR-11.414 (2.564-50.812)) and (unadjusted OR-6.214 9 (1.84-20.99)) for the genotype CC in severe category of COVID-19. Interestingly, the TC 10 genotype was also found to be positively associated with severe outcome (unadjusted OR-5.816

(1.489-22.709)), indicating association of C allele in imparting the risk of severe outcome. 12 

The study provides strong evidence that the presence of C allele of SNP (rs479200) of the 14 EGLN1 gene associates with severity in COVID-19 patients. Thus, the presence of C allele 15 may be a risk factor for COVID-19 severity. This study opens new avenues towards risk 16 assessment that include EGLN1 (rs479200) genotype testing and identifying patients with C 17 allele who might be prioritized for critical care. Interestingly, the COVID-19 hypoxia partially overlaps with high altitude pulmonary edema 10 (HAPE) with some atypical features such as preserved lung compliance, intrapulmonary shunt 11 and mild dyspnea. These features indicate towards loss of the homeostatic oxygen -sensing Focusing on the narrative of COVID-19 hypoxia, EGLN1 is one of the gene that has been 21 comprehensively studied in context of HAPE hypoxia 5 . The EGLN1 gene product-(2-22 oxoglutarate-dependent dioxygenase) regulates the hypoxia-inducible factor (HIF-α) via prolyl 23 hydroxylation. Whereas in hypoxic conditions inactivation of EGLN1 leads to increased HIF-24 α and subsequent dimerization with HIF-β activate the hypoxia response elements (HRE) 6,7 .

The HRE response may include, but is not limited to alterations in metabolic, cellular and is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 14, 2022. ; https://doi.org/10.1101/2022.03.11.22272214 doi: medRxiv preprint rs479200 and rs480902 SNPs have been repeatedly implicated for significant associations with 1 HAPE patients 5,14 . Mishra et al. 15 have observed a multi-fold increase in EGLN1 expression in 2 HAPE patients and significant association with the risk genotypes, their haplotypes and 3 interacting genotypes. The arterial oxygen saturation (SaO 2 ) levels were also found to be 4 inversely correlated with pulmonary artery systolic pressure (PASP) and EGLN1 expression.

SNPs from candidate genes have revealed significant differences of gene expression in HAPE 6 patients and healthy controls-ACE (rs4309), HSP70 (rs1008438), SP-A2 (rs1965708), PAI-1 7 (rs1799889), NOS (rs199983) and EGLN1 (rs480902) etc. 16 . The seven polymorphisms of 8 EGLN1 gene-rs1538664, rs479200, rs2486729, rs2790879, rs480902, rs2486736 and 9 rs973252; were found to be significantly different in HAPE patients and HAPE controls 14 . A 10 significant number of patients in severe COVID-19 mimic HAPE hypoxia 17 .

The lung transcriptome of COVID-19 patient implicated interaction of viral proteins ORF8 and 12 OS9 with EGLN1 and EGLN2 genes with potential role in disrupting the EGLN1-HIF oxygen 13 sensor mechanism 18,19 . It is worth noting that EGLN1 gene acts as a natural regulator of the 14 HIF-α protein and hence corroborates the hypothesis that inter-individual variations in the 15 EGLN1 gene might play role in the disease severity and subsequently risk assessment. 16 Interestingly, Roxadustat-HIF inhibitor shown to reduce ACE-2 expression, thereby inhibiting 17 entry and replication of SARS-CoV-2 inside lung epithelial cells, thus argued as potential 18 therapeutic agents for COVID-19 20 . In the present study, categorized COVID-19 patients were 19 analyzed for the SNP rs479200 of the EGLN1 gene and potential associations of the genotype 20 with disease severity were investigated. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 14, 2022. ; https://doi.org/10.1101/2022.03.11.22272214 doi: medRxiv preprint acid extractions were performed at the COVID-19 testing facility at ICMR-NIMR, Delhi, using 1 appropriate precautionary measures and personal protective equipment (PPE). DNA isolation 2 from small fractions of the clotted blood was performed using DNeasy Blood and Tissue kit, 3 Qiagen, Germany. Isolated DNA samples were quantified and purity was assessed using 4 Quawell UV-Vis Spectrophotometer Q5000.

Amplification for rs479200 and RFLP analysis 6 The EGLN1 gene sequence was retrieved from NCBI using Gene ID: 54583 for the egl-9 7 family hypoxia-inducible factor 1 [Homo sapiens (human)]. The reference SNP (rs479200) 8 was identified from dbSNP Reference (rs) SNP report at the chromosomal position is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 14, 2022. ; https://doi.org/10.1101/2022.03.11.22272214 doi: medRxiv preprint

Blood samples from 158 COVID-19 patients were tested by PCR-RFLP analysis to assess the 2 genotypes of SNP rs479200 of the EGLN1 gene, using restriction enzyme BsrGI (T/GTACA).

3 Table 1 shows the demographic profiles of the patients included in the study, classified 4 according to the disease severity. In our study, the mean age of the total number of participants 5 was 45.9±18.3, however the mean age of severe COVID-19 patients was 34.9±15.6, contrary 6 to the notion of prevalent severe complications in older patients. The mean age of COVID-19 7 patients in the asymptomatic and moderate disease was 49.7±17.9 and 54.3±15.7, respectively. 8 In addition, preponderance of male COVID-19 patients was observed compared to females, 9 across the clinical categories and also in a total number of participants, but it is unclear if this 10 distribution is an attribute to social or biological causes. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 14, 2022. ; https://doi.org/10.1101/2022.03.11.22272214 doi: medRxiv preprint Further, PCR-RFLP analysis revealed the genotypes of the SNP rs479200 of the EGLN1 gene 1 (Fig. 2) -TT genotype due to absence of 'C' at restriction site and hence no digestion (367 bp) 2 by the restriction enzyme; CC genotype due to the presence of 'C' at restriction site leading to 3 complete digestion (269 + 98 bp); TC genotype due to the presence of 'C' at restriction site, 4 only in one allele and incomplete digestion conferring heterozygous allele (367 + 269 + 98 bp ). The genotypes, allele frequencies of the EGLN1 gene rs479200 (T/C) and Hardy-Weinberg 8 Equilibrium (HWE) of the study population are summarized in Table 2 . The data showed high 9 heterozygosity across the clinical categories and in the total number of study patients. It was 10 observed that both the alleles (T & C) were uniformly present in the total study patients with a 11 high proportion of ancestral T allele, except for the severe category patients. The frequency of 12 'C' allele (0.664) was observed to be 2-fold higher in proportion than the 'T' allele (0.336).

The allele frequencies were in HWE status across the disease categories. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Whilst there is a consensus that severe COVID-19 patients present acute respiratory distress, Ventilation/perfusion (V/Q) mismatch, pulmonary hypertension, pulmonary capillary pressure 10 and reduced lung compliance 1 . HIF-α is shown to be central to the oxygen-sensing mechanism 11 recruited by cells in response to hypoxia, whose expression is regulated by 2 -oxoglutarate- The present study investigated the EGLN1 genotypes in asymptomatic, moderate and severe 23 COVID-19 patients at the time of diagnosis. Particularly, SNP rs479200 of the EGLN1 gene 24 that was previously found to be associated with HAPE susceptibility, aerobic capacity and is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 14, 2022. ;  https://doi.org/10.1101/2022.03.11.22272214 doi: medRxiv preprint predisposition to pre-eclampsia in multiple studies was explored further; where in SNP 1 rs479200 (C > T) results in three distinct genotypes-homozygous (CC & TT) and heterozygous 2 (TC), with C & T as major and minor alleles, respectively. Statistical analysis SNP rs479200 3 revealed that both the alleles are present in equal proportion in asymptomatic and moderate 4 categories of COVID-19 patients, but overrepresentation of C allele (2-fold higher than T 5 allele) in severe COVID-19 was peculiar. The CC genotype was significantly overrepresented 6 in severe COVID-19 patients (p-value = 0.047). Multinomial logistic regression was performed 7 to evaluate the association of different genotypes with disease severity, which estimated (OR- in asymptomatic vs severe categories of COVID-19. Moreover, the TC genotype was also 10 found to be strongly associated with severe COVID-19, indicating the role of the C allele as a 11 risk factor. 12 Transcription of the hypoxia response elements (HRE) in normoxic conditions is regulated and 13 mediated by 2ODD-a gene product of EGLN1 gene, however in hypoxic conditions, inactive 14 2ODD cannot inhibit HIF-α and HIF-β dimerization leading to activation of HRE (Fig. 3a, b ) 15 Considering the genotype data of the EGLN1 gene, TT genotype is correlated with higher 16 expression of EGLN1 gene resulting in overproduction of 2ODD 5 and conversely, the CC 17 genotype results in lower expression of EGLN1 gene producing less 2ODD. Accordingly, 18 Aggarwal et al. 5 previously showed that individuals residing at low altitudes with TT genotype 19 do not respond well in hypoxic conditions succumbing to HAPE at high altitudes.

Overproduction of 2ODD in the presence of T allele (Fig. 3c ) results in minimal HIF-α levels, 21 rendering the individuals hypo-responsive towards hypoxia. In contrast, the ancestral CC 22 genotype in highlanders imparts a physiological adaptation to respond well in hypoxic 23 conditions. Notably, C allele-the identified risk factor in severe COVID-19, producing inactive 24 2ODD in hypoxic conditions, accumulates high levels of HIF-α making them hyper-responsive 25 towards hypoxia with activation of HRE (Fig. 3d) . The hyper-responsiveness towards hypoxia is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 14, 2022. must be investigated in different settings. It is worth noting that deducing the genotype of SNP 1 rs479200 can be easily accomplished in 4-6 hours' time, equivalent to a COVID-19 RT-PCR 2 test. Therefore, the presence of C allele as a risk factor in severe COVID-19 might serve as a is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 14, 2022. ; https://doi.org/10.1101/2022.03.11.22272214 doi: medRxiv preprint Acknowledgement 1 This work was funded by intramural funding support from ICMR-NIMR, Delhi. We thank Drs.

2 Amit Sharma and O. P. Singh for their critical feedback in the study. We thank the NIMR 3 biorepository team members for procuring the COVID-19 infected patient samples during the 4 first wave in India. The publication bears the NIMR publication committee no. RIC-11/2022. 5 We thank Mr. Puneet Saini and Ramakant Pal from ICMR-NIMR, stores for timely 6 procurement of reagents in unprecedented COVID-19 lockdown situation. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 14, 2022. ; https://doi.org/10.1101/2022.03.11.22272214 doi: medRxiv preprint Bibliography 1

Acute Respiratory Distress Syndrome and High Altitude Pulmonary Edema: 3 Therapeutic Implications

COVID-19 pneumonia: different respiratory treatments for different 5 phenotypes?

Proteomic analysis of up-regulated proteins in human promonocyte 7 cells expressing severe acute respiratory syndrome coronavirus 3C-like protease

Host genetic factors determining COVID-19 susceptibility and 10 severity

EGLN1 involvement in high-altitude adaptation revealed through 12 genetic analysis of extreme constitution types defined in Ayurveda

Regulation of oxygen homeostasis by hypoxia-Inducible factor 1. 15 Physiology vol

Hypoxia: A key feature of COVID-19 17 launching activation of HIF-1 and cytokine storm

Association of polymorphisms of rs479200 and rs480902 in 20 EGLN1 gene with hypoxia adaptation in high altitude in Tibetans

Association of EGLN1 23 genetic polymorphisms with SpO 2 responses to acute hypobaric hypoxia in a Japanese 24 cohort

Association of EGLN1 gene with high aerobic capacity of 26

Peruvian Quechua at high altitude

Novel association of 29 SNP rs479200 in EGLN1 gene with predisposition to preeclampsia

Genenames.org: The HGNC and VGNC resources in 2021

Gene-Gene Interaction between EPAS1 and EGLN1 in Patients with 37

EGLN1 variants influence 40 adaptation

Correlation between single nucleotide polymorphisms in hypoxia-related 2 genes and susceptibility to acute high-altitude pulmonary edema

Intensive Care Medicine COVID-19 pneumonia: different 5 respiratory treatment for different phenotypes?

COVID-19 patient and systems biology predictions suggest impaired surfactant 8 production which may be druggable by surfactant therapy

The EGLN-HIF O2-Sensing System: Multiple Inputs and 11

Hypoxic and pharmacological activation of HIF inhibits SARS-13

CoV-2 infection of lung epithelial cells

COVID-19 lung injury and high altitude pulmonary 15 edema: A false equation with dangerous implications

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: 18 Pros and Cons